Company: GCL
Filing Date: 2025-07-31
Form Type: 424B3
Source: 0001213900-25-070094
Chunk: 147

Company: GCL Global Holdings Ltd
Filing Date: 2025-07-31
Form: 424B3
Chunk 147
---
 convertible notes at one or more additional closings, with the aggregate original principal amount
not to exceed $42,600,000, at a purchase price of $38,340,000 under the facility, subject to satisfaction of certain conditions specified
in the ATW SPA. The Notes have a three-year term and bear interest at 6% per annum, payable monthly, at GCL’s option, in cash or,
provided that certain conditions are met, in ordinary shares. The proceeds shall be used for general corporate and working capital purposes.

In connection with the ATW
SPA, the Company and the Investor entered into a Registration Rights Agreement pursuant to which the Company has agreed to provide certain
registration rights with respect to the Registrable Securities (which include Conversion Shares and is defined in the Registration Rights
Agreement) and file a registration statement with the SEC to register the Registrable Securities within twelve (12) months from the Initial
Closing Date, and to have such registration statement effective within the earlier of the 15th month anniversary of the Initial Closing
Date and the second business day after the date the Company is notified by the SEC that such registration statement will not be reviewed
or will not be subject to further review.

OCBC Warrant

In
connection with that certain Facility Letter dated as of October 1, 2024, as supplemented by the Supplemental Letter dated as of March
12, 2025 and July 7, 2025 between Epicsoft Asia Pte. Ltd. (the “Borrower”), a wholly-owned subsidiary of GCL Global Holdings
Ltd. (the “Company” or “GCL”), and Oversea-Chinese Banking Corporation Limited (“OCBC”) for a financing
of up to SGD5,000,000 (the “Facility Agreement”), the Company issued to OCBC a warrant (the “OCBC Warrant”) to
purchase up to 899,281 ordinary shares of the Company (the “Warrant Shares”) at an exercise price of US$4.17 per share (the
“Exercise Price”) to meet one of the conditions precedent for the Borrower to draw down funds under the Facility Agreement.
The aggregate Exercise Price payable for the total number of Warrant Shares purchasable under the Warrant shall be US$3,750,000, and shall
first be used to repay all principal, interest and other amounts outstanding under the Facility Agreement with the remainder, if any,
for the Borrower’s working capital. The Warrant